What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis
about
sameAs
Neoatherosclerosis: Coronary stents seal atherosclerotic lesions but result in making a new problem of atherosclerosisThe safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart diseaseRapamycin regulates the expression and activity of Krüppel-like transcription factor 2 in human umbilical vein endothelial cellsComparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry.Long-term outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice: a Canadian experience.Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells.Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis.Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.Update on drug-eluting coronary stents.Adjunctive balloon postdilatation after stent deployment: is it still necessary with drug-eluting stents?A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease.Efficacy and safety of drug-eluting stents: current best available evidence.Very late stent thrombosis after drug-eluting stent implantation in a patient without aspirin and clopidogrel resistanceComparison of one-year clinical outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice.Drug-eluting stents: a comprehensive appraisal.Drug-eluting stent coatings.Benefits of and safety concerns associated with drug-eluting coronary stents.How safe and how good are drug-eluting stents?Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation.Causes, assessment, and treatment of stent thrombosis--intravascular imaging insights.Thrombosis after stent implantation: how much of a problem is there?Three year follow-up of the sirolimus-eluting stent and the paclitaxel-eluting stent in daily practice.Everolimus-eluting stents and zotarolimus-eluting stents for percutaneous coronary interventions: two-year outcomes in New York State.Meta-analysis shows similar risk of thrombosis after drug-eluting stent, bare-metal stent, or angioplasty.Drug-eluting stents: the continuing controversy -- a perspective on the downside of drug-eluting stents.Incremental age-related one-year MACCE after acute myocardial infarction in the drug-eluting stent era (from KAMIR-NIH registry)Long-term safety of drug-eluting stents in patients on warfarin treatment
P2860
Q26774540-1A301524-2C9D-41D9-AA21-5F3B8ADB381EQ28200757-5CF9CB19-C798-49F4-A544-47615E122A8DQ28482627-969C3748-D701-4988-BDFB-2771096EC7E7Q31043691-39CFDF88-3070-497B-9F54-C3F9946DE05CQ33776103-52C660CB-BBD3-47E9-B043-8CFE475A9563Q33776274-F79DD9E7-9482-4A88-9D82-12DADC7BD7CEQ35927338-A89A0E09-40F4-49B4-88F0-A88EF9D96BC7Q36046996-01AA0FC4-0B7A-4CDC-8A47-E260781C06E1Q36266053-10B6E3AD-0139-468D-B4E2-362E0FD6FB42Q36398733-C6EDBB4F-B1C9-42AC-9239-6A8DC6223356Q36488244-C8020116-138B-4980-8138-F1D025CC6171Q36639071-3D5BE992-0371-42A0-907D-EADB13E97651Q36854510-BFCA5E5B-A777-4B48-80BE-F514E9F3A769Q37098303-7C4EEF81-DD40-487C-B9AB-C220C34F6494Q37445860-4B51C04E-D7D1-4C2B-90E5-D4F0CEAD7F01Q37668357-9904D40E-1B6E-40AF-9271-8F60780589FBQ37707419-A8F9E18B-90F2-4B08-8975-442C77FDCC9AQ37859760-E73331FA-967D-41A3-B82C-37DB30E5DA60Q38063290-B78BD80E-EC2B-4D98-9590-105D87BE580AQ38381419-C9E4ED68-5D11-4BF7-8266-29EA311AC0E4Q40097851-7AC4569B-BFFF-453B-94D2-B739A9392601Q43219094-CE213B70-3DCA-4637-A662-60481DAC14C2Q46073499-D4ABD6DD-98B2-498B-9B98-907E1AE446A8Q46527895-6899083E-94B0-4206-AA77-3211583F124FQ46753314-6F0BD46E-164F-4E72-B2F9-85D7885550DEQ57821037-A9A195A8-BEF0-4363-97A0-2136DC477FCDQ57914557-E64B215F-779B-4927-90CB-937698F3FF6F
P2860
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
What is the risk of stent thro ...... intervention?: a meta-analysis
@ast
What is the risk of stent thro ...... intervention?: a meta-analysis
@en
What is the risk of stent thro ...... intervention?: a meta-analysis
@nl
type
label
What is the risk of stent thro ...... intervention?: a meta-analysis
@ast
What is the risk of stent thro ...... intervention?: a meta-analysis
@en
What is the risk of stent thro ...... intervention?: a meta-analysis
@nl
prefLabel
What is the risk of stent thro ...... intervention?: a meta-analysis
@ast
What is the risk of stent thro ...... intervention?: a meta-analysis
@en
What is the risk of stent thro ...... intervention?: a meta-analysis
@nl
P2093
P1476
What is the risk of stent thro ...... intervention?: a meta-analysis
@en
P2093
Anthony A Bavry
Deepak L Bhatt
Dharam J Kumbhani
Thomas J Helton
P356
10.1016/J.JACC.2004.11.064
P407
P577
2005-03-15T00:00:00Z